Suppr超能文献

miR-195、miR-455-3p 和 miR-10a(*) 参与胶质母细胞瘤细胞获得性替莫唑胺耐药。

miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.

机构信息

Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan.

出版信息

Cancer Lett. 2010 Oct 28;296(2):241-8. doi: 10.1016/j.canlet.2010.04.013. Epub 2010 May 4.

Abstract

To identify microRNAs (miRNAs) specifically involved in the acquisition of temozolomide (TMZ) resistance in glioblastoma multiforme (GBM), we first established a resistant variant, U251R cells from TMZ-sensitive GBM cell line, U251MG. We then performed a comprehensive analysis of miRNA expressions in U251R and parental cells using miRNA microarrays. miR-195, miR-455-3p and miR-10a( *) were the three most up-regulated miRNAs in the resistant cells. To investigate the functional role of these miRNAs in TMZ resistance, U251R cells were transfected with miRNA inhibitors consisting of DNA/LNA hybrid oligonucleotides. Suppression of miR-455-3p or miR-10a( *) had no effect on cell growth, but showed modest cell killing effect in the presence of TMZ. On the other hand, knockdown of miR-195 alone displayed moderate cell killing effect, and combination with TMZ strongly enhanced the effect. In addition, using in silico analysis combined with cDNA microarray experiment, we present possible mRNA targets of these miRNAs. In conclusion, our findings suggest that those miRNAs may play a role in acquired TMZ resistance and could be a novel target for recurrent GBM treatment.

摘要

为了鉴定在多形性胶质母细胞瘤(GBM)中获得替莫唑胺(TMZ)耐药性过程中特异性涉及的 microRNAs(miRNAs),我们首先从 TMZ 敏感的 GBM 细胞系 U251MG 中建立了耐药变体 U251R 细胞。然后,我们使用 miRNA 微阵列对 U251R 和亲本细胞中的 miRNA 表达进行了全面分析。miR-195、miR-455-3p 和 miR-10a()是耐药细胞中上调最明显的三个 miRNA。为了研究这些 miRNA 在 TMZ 耐药性中的功能作用,我们用由 DNA/LNA 杂交寡核苷酸组成的 miRNA 抑制剂转染 U251R 细胞。抑制 miR-455-3p 或 miR-10a()对细胞生长没有影响,但在存在 TMZ 的情况下显示出适度的细胞杀伤作用。另一方面,单独敲低 miR-195 显示出适度的细胞杀伤作用,与 TMZ 联合使用可显著增强该作用。此外,我们通过计算分析结合 cDNA 微阵列实验,提出了这些 miRNA 的可能 mRNA 靶标。总之,我们的研究结果表明,这些 miRNA 可能在获得性 TMZ 耐药性中发挥作用,可能成为复发性 GBM 治疗的新靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验